Solvac S.A.
Holding company managing a >30% stake in global advanced materials & specialty chemicals leaders.
SOLV | BR
Overview
Corporate Details
- ISIN(s):
- BE0003545531
- LEI:
- 549300EO33NRZ1PZRW58
- Country:
- Belgium
- Address:
- RUE DES CHAMPS ELYSÉES 43, 1050 BRUSSELS
- Website:
- https://www.solvac.be/
- Sector:
- Mining and quarrying
- Industry:
- Extraction of natural gas
Description
Solvac S.A. is a holding company established in 1983, acting as the primary investment vehicle for the descendants of Solvay's founding families. The company's core activity is the management of its long-term strategic shareholdings in two global companies: Solvay S.A. and Syensqo S.A. Solvac holds a significant participation of over 30% in the capital of both entities. As a stable reference shareholder, its mission is to support the sustainable growth and value creation of these leaders in advanced materials and specialty chemicals, thereby generating returns for its own shareholders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-01 18:00 |
Audit Report / Information
25MLM0272 Solvac SA Limited review HY report EN (FR).pdf
|
French | 21.8 KB | ||
| 2025-08-01 18:00 |
Audit Report / Information
25MLM0272 Solvac SA Limited review HY report FR.pdf
|
French | 21.8 KB | ||
| 2025-08-01 18:00 |
Audit Report / Information
25MLM0272 Solvac SA Limited review HY report NL.pdf
|
Dutch | 21.5 KB | ||
| 2025-08-01 18:00 |
Earnings Release
Press Release 01 august 2025.pdf
|
English | 340.1 KB | ||
| 2025-08-01 18:00 |
Earnings Release
Communique´ de Presse.pdf
|
French | 318.9 KB | ||
| 2025-08-01 18:00 |
Earnings Release
Persbericht 01 augustus 2025.pdf
|
Dutch | 342.6 KB | ||
| 2025-05-13 07:30 |
Notice of Dividend Amount
Press release 13 May - Dividend.pdf
|
English | 81.7 KB | ||
| 2025-05-13 07:30 |
Notice of Dividend Amount
CP 13 mai 2025 - Dividende.pdf
|
French | 73.1 KB | ||
| 2025-05-13 07:30 |
Notice of Dividend Amount
Persbericht 13 mei - Dividend.pdf
|
Dutch | 80.9 KB | ||
| 2025-04-25 20:45 |
Board/Management Information
2025 - Resume Tanguy du Monceau de Bergendal.pdf
|
English | 234.5 KB | ||
| 2025-04-25 20:45 |
Proxy Solicitation & Information Statement
2025 - Procuration.pdf
|
French | 130.8 KB | ||
| 2025-04-25 20:45 |
Proxy Solicitation & Information Statement
2025 - Volmacht.pdf
|
Dutch | 128.3 KB | ||
| 2025-04-25 20:45 |
Pre-Annual General Meeting Information
2025 - Avis de participation.pdf
|
French | 90.8 KB | ||
| 2025-04-25 20:45 |
Pre-Annual General Meeting Information
2025 - Bericht van deelname.pdf
|
Dutch | 20.0 KB | ||
| 2025-04-25 20:45 |
Pre-Annual General Meeting Information
2025 - Note explicative sur l'ordre du jour AGO.pdf
|
French | 159.0 KB |
Automate Your Workflow. Get a real-time feed of all Solvac S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Solvac S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Solvac S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-03 | POMOFI | Close relation | Buy | 650 | 66,300.00 EUR |
| 2025-01-30 | POMOFI | Close relation | Buy | 1,000 | 100,000.00 EUR |
| 2025-01-24 | POMOFI | Close relation | Buy | 1,500 | 153,495.00 EUR |
| 2025-01-16 | POMOFI | Close relation | Buy | 2,233 | 228,011.63 EUR |
| 2024-10-15 | Solvay Patrick | Board | Sell | 796,557 | 83,750,002.98 EUR |
| 2024-08-12 | POMOFI | Close relation | Buy | 800 | 82,400.00 EUR |
| 2024-06-14 | POMOFI | Close relation | Buy | 1,575 | 176,022.00 EUR |
| 2024-06-06 | POMOFI | Close relation | Buy | 1,150 | 130,272.00 EUR |
| 2024-01-08 | POMOFI | Close relation | Buy | 100 | 12,300.00 EUR |
| 2024-01-02 | POMOFI | Close relation | Buy | 400 | 49,800.00 EUR |
Peer Companies
/other/Aino_Health_AB_publ-logo.png){kind=logo}
